Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Metformin for Treatment of ABCA4 Retinopathy
NCT04545736Phase 2Active, not recruiting
- Sponsor
- National Eye Institute
- Start
- Nov 2020
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in ABCA4 retinopathy (ABCA4R), sponsored by National Eye Institute. Started Nov 2020; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
ABCA4 retinopathy (ABCA4R)
Beyond the preview
Go deeper on NCT04545736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04545736.